OAM
IBB icon

Oppenheimer Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Oppenheimer Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,424
Closed -$3.35M – 1183
2024
Q2 		$3.35M Buy
24,424
+2,141
+10% +$286K 0.04% 403
2024
Q1 		$3.06M Sell
22,283
-2,493
-10% -$340K 0.04% 380
2023
Q4 		$3.37M Sell
24,776
-554
-2% -$67.6K 0.05% 386
2023
Q3 		$3.1M Sell
25,330
-513
-2% -$65.2K 0.05% 382
2023
Q2 		$3.28M Sell
25,843
-336
-1% -$43.6K 0.05% 387
2023
Q1 		$3.38M Sell
26,179
-276
-1% -$36.1K 0.05% 354
2022
Q4 		$3.47M Buy
+26,455
New +$3.42M 0.06% 348
2021
Q4 		– Sell
-2,703
Closed -$437K – 1242
2021
Q3 		$437K Sell
2,703
-137
-5% -$23.1K 0.01% 968
2021
Q2 		$465K Sell
2,840
-31
-1% -$4.78K 0.01% 983
2021
Q1 		$432K Sell
2,871
-82
-3% -$13K 0.01% 952
2020
Q4 		$447K Buy
+2,953
New +$422K 0.01% 895
2020
Q3 		– Sell
-8,752
Closed -$1.2M – 1111
2020
Q2 		$1.2M Buy
+8,752
New +$1.12M 0.02% 543
2017
Q4 		– Sell
-600
Closed -$67K – 1253
2017
Q3 		$67K Sell
600
-120
-17% -$12.8K ﹤0.01% 1297
2017
Q2 		$74K Buy
720
+24
+3% +$2.36K ﹤0.01% 1262
2017
Q1 		$68K Buy
+696
New +$66.6K ﹤0.01% 1275

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Oppenheimer Asset Management's IBB Position: Q3 2024 in Review

Oppenheimer Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 24,424 shares — an estimated $3.35M sold.

Oppenheimer Asset Management first reported a position in IBB in Q1 2017 and held it in 15 quarters. The position peaked at $3.47M in Q4 2022. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Oppenheimer Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 24,424 iShares Biotechnology ETF shares in Q3 2024, an estimated $3.35M.
  • Oppenheimer Asset Management first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 15 quarters.
  • Oppenheimer Asset Management's iShares Biotechnology ETF position peaked at $3.47M in Q4 2022.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Oppenheimer Asset Management's 13F filing for Q3 2024, filed 5 Nov 2024.